{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T08:58:40Z","timestamp":1771577920861,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajicjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Infection Control"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.ajic.2014.12.010","type":"journal-article","created":{"date-parts":[[2015,3,30]],"date-time":"2015-03-30T11:48:10Z","timestamp":1427716090000},"page":"358-364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Influence of antimicrobial consumption on gram-negative bacteria in inpatients receiving antimicrobial resistance therapy from 2008-2013 at a tertiary hospital in Shanghai, China"],"prefix":"10.1016","volume":"43","author":[{"given":"Wei","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajic.2014.12.010_bib1","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1001\/jama.2014.2465","article-title":"The perpetual challenge of antimicrobial resistance","volume":"311","author":"Fauci","year":"2014","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.ajic.2014.12.010_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ijantimicag.2012.07.009","article-title":"Antibiotic resistance amongst healthcare-associated pathogens in China","volume":"40","author":"Yezli","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ajic.2014.12.010_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0140-6736(08)61956-X","article-title":"Antibiotic resistance in China\u2013a major future challenge","volume":"373","author":"Heddini","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ajic.2014.12.010_bib4","doi-asserted-by":"crossref","first-page":"e1001556","DOI":"10.1371\/journal.pmed.1001556","article-title":"Changes in Chinese policies to promote the rational use of antibiotics","volume":"10","author":"Xiao","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajic.2014.12.010_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1473-3099(13)70011-2","article-title":"Legislation of clinical antibiotic use in China","volume":"13","author":"Xiao","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajic.2014.12.010_bib6","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/heapol\/czs116","article-title":"The impact of the National Essential Medicines Policy on prescribing behaviours in primary care facilities in Hubei province of China","volume":"28","author":"Yang","year":"2013","journal-title":"Health Policy Plan"},{"key":"10.1016\/j.ajic.2014.12.010_bib7","unstructured":"Ministry of Health, People's Republic of China. Administrative regulations for clinical use of antibacterial agents. Ministry of Health: Beijing, China; May,\u00a02012."},{"key":"10.1016\/j.ajic.2014.12.010_bib8","series-title":"Guidelines for ATC Classification and DDD Assignment. WHO Collaborating Centre for Drug Statistics Methodology","year":"2012"},{"key":"10.1016\/j.ajic.2014.12.010_bib9","series-title":"Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement. Document M100\u2013S19","year":"2009"},{"key":"10.1016\/j.ajic.2014.12.010_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0924-8579(99)00135-1","article-title":"Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis","volume":"14","author":"L\u00f3pez-Lozano","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ajic.2014.12.010_bib11","series-title":"Time series analysis: forecasting and control","author":"Box","year":"1976"},{"key":"10.1016\/j.ajic.2014.12.010_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/096228029600500102","article-title":"Box-Jenkins modelling in medical research","volume":"5","author":"Helfenstein","year":"1996","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.ajic.2014.12.010_bib13","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1016\/j.ijid.2013.01.030","article-title":"The impact of the increased use of piperacillin\/tazobactam on the selection of antibiotic resistance among invasive Escherichia coli and Klebsiella pneumoniae isolates","volume":"17","author":"Lee","year":"2013","journal-title":"Int J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.ajic.2014.12.010_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1469-0691.2007.01864.x","article-title":"Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam","volume":"14","author":"Peterson","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 5","key":"10.1016\/j.ajic.2014.12.010_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1469-0691.2005.01238.x","article-title":"Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance","volume":"11","author":"Peterson","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ajic.2014.12.010_bib16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.diagmicrobio.2013.11.011","article-title":"Prevalence of antibiotic resistance in US hospitals","volume":"78","author":"Edelsberg","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ajic.2014.12.010_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijantimicag.2011.01.009","article-title":"High burden of antimicrobial resistance in Asia","volume":"37","author":"Jean","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ajic.2014.12.010_bib18","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1128\/AAC.47.6.1887-1894.2003","article-title":"Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone","volume":"47","author":"Hocquet","year":"2003","journal-title":"Antimicrobial Agents Chemother"},{"issue":"Suppl 4","key":"10.1016\/j.ajic.2014.12.010_bib19","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1086\/382690","article-title":"\u201cCollateral damage\u201d from cephalosporin or quinolone antibiotic therapy","volume":"38","author":"Paterson","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2014.12.010_bib20","first-page":"72","article-title":"Multidrug-resistant Escherichia coli and Klebsiella pneumoniae: treatment, selection and international spread","volume":"840","author":"T\u00e4ngd\u00e9n","year":"2012"},{"key":"10.1016\/j.ajic.2014.12.010_bib21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nrmicro2319","article-title":"Antibiotic resistance and its cost: is it possible to reverse resistance?","volume":"8","author":"Andersson","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ajic.2014.12.010_bib22","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1093\/jac\/dkq351","article-title":"Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacin-resistant Escherichia coli in a university hospital","volume":"65","author":"Gallini","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2014.12.010_bib23","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/jac\/dkq525","article-title":"Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community","volume":"66","author":"Vernaz","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2014.12.010_bib24","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1126\/science.1220761","article-title":"The shared antibiotic resistome of soil bacteria and human pathogens","volume":"337","author":"Forsberg","year":"2012","journal-title":"Science"}],"container-title":["American Journal of Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655314013960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655314013960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:42:23Z","timestamp":1759297343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196655314013960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0196655314013960"],"URL":"https:\/\/doi.org\/10.1016\/j.ajic.2014.12.010","relation":{},"ISSN":["0196-6553"],"issn-type":[{"value":"0196-6553","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of antimicrobial consumption on gram-negative bacteria in inpatients receiving antimicrobial resistance therapy from 2008-2013 at a tertiary hospital in Shanghai, China","name":"articletitle","label":"Article Title"},{"value":"American Journal of Infection Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajic.2014.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}